文献速递口腔修复与种植牙周病

HIV血清阳性患者牙种植体12年随访研究

Dental implants in patients seropositive for HIV: A 12-year follow-up study.
PubMed 文献 · J Am Dent Assoc · 2020-01-01

该前瞻性研究对9例HIV阳性患者共18枚种植体进行12年随访,评估其长期存留情况。结果显示种植体成功率与健康患者相当,表明HIV阳性并非种植修复的禁忌证。

要点

  • HIV阳性患者种植体12年长期存留率与健康人群相当
  • 8例患者病毒载量检测不到,1例为48拷贝/毫升
  • 随访期间无种植体松动,种植修复非HIV阳性禁忌

核心结论

  • HIV阳性患者牙种植治疗可获得长期存留,成功率与健康患者相当,种植修复不是HIV阳性患者的禁忌证。

研究设计与样本

  • 前瞻性研究,纳入9例HIV阳性患者共18枚种植体,在口腔修复和功能负载后随访12年。

主要发现

  • 8例患者病毒载量检测不到,1例为48拷贝/毫升。
  • CD4 T淋巴细胞计数范围227至1000个/立方毫米,均值(标准差)564(271.13)个/立方毫米。
  • 9例中5例(55.5%)有可见菌斑,5例(55.5%)探诊出血,无种植体松动。
  • 功能负载6个月、12个月和12年的影像学平均(标准差)边缘骨丧失分别为0.32(0.23)mm、0.37(0.23)mm和2.43(1.48)mm。

临床怎么用

  • 对HIV血清阳性患者可考虑种植修复,但需关注菌斑控制和探诊出血等牙周维护指标。

局限性

  • 样本量小(9例患者、18枚种植体),可能限制结果的普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OVERVIEW: Patients seropositive HIV and AIDS represent a group of patients who experience longer longevity at the expense of effective therapies for infection control and related opportunistic diseases. However, the prolonged use of these drugs is often associated with adverse events, which theoretically may influence dental management and the long-term stability of dental implants. The objective of this study was to prospectively evaluate a group of HIV-positive people from a previous study who had received dental implants for 12 years after oral rehabilitation and functional loading. CASE DESCRIPTION: Nine patients with a total of 18 implants participated in this study. Viral load was undetectable in 8 patients, with 1 who had 48 copies/milliliter. The cluster of differentiation 4 T lymphocyte count ranged from 227 through 1,000 cells/cubic millimeter, mean (standard deviation [SD]) 564 (271.13) cells/mm3. Five of the 9 (55.5%) patients had visible plaque, and 5 (55.5%) had bleeding on probing with no implant mobility. Radiographs obtained at 6 months, 12 months, and 12 years of functional loading showed mean (SD) marginal bone losses of 0.32 (0.23) mm, 0.37 (0.23) mm, and 2.43 (1.48), respectively. CONCLUSION AND PRACTICAL IMPLICATIONS: These results suggest that dental implant treatment in HIV-positive patients achieved long-term survival, with a success rate comparable with that observed in healthy patients, indicating that implant rehabilitation is not a contraindication for HIV-positive patients.

来源:J Am Dent Assoc,查看原文。版权归原作者所有。

引用

  1. Oliveira MA, Pallos D, Mecca F, et al. Dental implants in patients seropositive for HIV: A 12-year follow-up study. J Am Dent Assoc. 2020. PMID: 33121608. doi:10.1016/j.adaj.2020.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。